162 related articles for article (PubMed ID: 10353046)
1. Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department.
Sherlock K; Wolff K; Hay AW; Conner M
J Accid Emerg Med; 1999 May; 16(3):194-7. PubMed ID: 10353046
[TBL] [Abstract][Full Text] [Related]
2. Solid-phase extraction for profiling of ecstasy tablets.
Rashed AM; Anderson RA; King LA
J Forensic Sci; 2000 Mar; 45(2):413-7. PubMed ID: 10782963
[TBL] [Abstract][Full Text] [Related]
3. mCPP: an undesired addition to the ecstasy market.
Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
[TBL] [Abstract][Full Text] [Related]
4. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
[TBL] [Abstract][Full Text] [Related]
5. Development of a Library Search-Based Screening System for 3,4-Methylenedioxymethamphetamine in Ecstasy Tablets Using a Portable Near-Infrared Spectrometer.
Tsujikawa K; Yamamuro T; Kuwayama K; Kanamori T; Iwata YT; Miyamoto K; Kasuya F; Inoue H
J Forensic Sci; 2016 Sep; 61(5):1208-14. PubMed ID: 27362667
[TBL] [Abstract][Full Text] [Related]
6. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
Cheng WC; Poon NL; Chan MF
J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
[TBL] [Abstract][Full Text] [Related]
7. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
[TBL] [Abstract][Full Text] [Related]
8. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
Parrott AC
Psychopharmacology (Berl); 2004 May; 173(3-4):234-41. PubMed ID: 15007594
[TBL] [Abstract][Full Text] [Related]
9. Content of ecstasy in the Netherlands: 1993-2008.
Vogels N; Brunt TM; Rigter S; van Dijk P; Vervaeke H; Niesink RJ
Addiction; 2009 Dec; 104(12):2057-66. PubMed ID: 19804461
[TBL] [Abstract][Full Text] [Related]
10. Is online information on ecstasy tablet content safe?
Vrolijk RQ; Brunt TM; Vreeker A; Niesink RJ
Addiction; 2017 Jan; 112(1):94-100. PubMed ID: 27518128
[TBL] [Abstract][Full Text] [Related]
11. The content of ecstasy tablets: implications for the study of their long-term effects.
Cole JC; Bailey M; Sumnall HR; Wagstaff GF; King LA
Addiction; 2002 Dec; 97(12):1531-6. PubMed ID: 12472637
[TBL] [Abstract][Full Text] [Related]
12. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
13. The variability of ecstasy tablets composition in Brazil.
Togni LR; Lanaro R; Resende RR; Costa JL
J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of 3,4-methylenedioxymethamphetamine by thin-layer chromatography in ecstasy illicit pills in Tehran.
Shetab Boushehri SV; Tamimi M; Kebriaeezadeh A
Toxicol Mech Methods; 2009 Nov; 19(9):565-9. PubMed ID: 20047512
[TBL] [Abstract][Full Text] [Related]
15. A turn-on fluorogenic probe for detection of MDMA from ecstasy tablets.
Moreno D; Díaz de Greñu B; García B; Ibeas S; Torroba T
Chem Commun (Camb); 2012 Mar; 48(24):2994-6. PubMed ID: 22314849
[TBL] [Abstract][Full Text] [Related]
16. Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets.
Deconinck E; Van Campenhout R; Aouadi C; Canfyn M; Bothy JL; Gremeaux L; Blanckaert P; Courselle P
Talanta; 2019 Apr; 195():142-151. PubMed ID: 30625524
[TBL] [Abstract][Full Text] [Related]
17. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.
Brunt TM; Koeter MW; Niesink RJ; van den Brink W
Psychopharmacology (Berl); 2012 Apr; 220(4):751-62. PubMed ID: 21993879
[TBL] [Abstract][Full Text] [Related]
18. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
[TBL] [Abstract][Full Text] [Related]
19. 2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market.
Giroud C; Augsburger M; Rivier L; Mangin P; Sadeghipour F; Varesio E; Veuthey JL; Kamalaprija P
J Anal Toxicol; 1998 Sep; 22(5):345-54. PubMed ID: 9737327
[TBL] [Abstract][Full Text] [Related]
20. Analysis of ecstasy tablets: comparison of reflectance and transmittance near infrared spectroscopy.
Schneider RC; Kovar KA
Forensic Sci Int; 2003 Jul; 134(2-3):187-95. PubMed ID: 12850416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
